NF-κB in the New Era of Cancer Therapy

Area of Science:

• Oncology
• Molecular Biology
• Cancer Genetics

Background:

• Despite declining mortality, most cancers remain incurable, presenting a significant medical challenge.
• Recent advances in cancer genetics and genomics have identified new cancer hallmarks, including metabolic reprogramming and immune evasion.

Purpose of the Study:

• To review the therapeutic potential of Nuclear Factor kappa B (NF-κB) transcription factors in cancer.
• To explore signaling pathways controlling NF-κB activity in the context of novel cancer hallmarks and therapies.

Main Methods:

• Literature review of recent progress in cancer genetics, genomics, and immunology.
• Analysis of NF-κB-dependent vulnerabilities and their role in cancer hallmarks.
• Examination of therapeutic strategies involving NF-κB modulation and cutting-edge cancer treatments.

Main Results:

• Identification of novel NF-κB-dependent cancer vulnerabilities associated with energy metabolism and immune evasion.
• Demonstration of improved patient stratification based on these discoveries.
• Emergence of new drug combinations utilizing cutting-edge therapies targeting NF-κB pathways.

Conclusions:

• NF-κB transcription factors and their regulatory pathways represent promising therapeutic targets in oncology.
• Targeting NF-κB offers potential for improved patient stratification and novel combination therapies.
• This review provides an updated perspective on leveraging NF-κB in the evolving landscape of cancer treatment.